Published in Blood on November 01, 1992
Identification of a point mutation in the catalytic domain of the protooncogene c-kit in peripheral blood mononuclear cells of patients who have mastocytosis with an associated hematologic disorder. Proc Natl Acad Sci U S A (1995) 3.85
Identification of mutations in the coding sequence of the proto-oncogene c-kit in a human mast cell leukemia cell line causing ligand-independent activation of c-kit product. J Clin Invest (1993) 3.57
Cytokines in asthma. Thorax (1999) 2.64
Mast cells and mastocytosis. Blood (2008) 2.32
The c-kit receptor, stem cell factor, and mast cells. What each is teaching us about the others. Am J Pathol (1993) 1.55
Phase II study of dasatinib in Philadelphia chromosome-negative acute and chronic myeloid diseases, including systemic mastocytosis. Clin Cancer Res (2008) 1.39
Recombinant human stem cell factor (kit ligand) promotes human mast cell and melanocyte hyperplasia and functional activation in vivo. J Exp Med (1996) 1.27
Human airway smooth muscle promotes human lung mast cell survival, proliferation, and constitutive activation: cooperative roles for CADM1, stem cell factor, and IL-6. J Immunol (2008) 1.23
Oncogenic Kit controls neoplastic mast cell growth through a Stat5/PI3-kinase signaling cascade. Blood (2008) 1.16
Unique effects of KIT D816V in BaF3 cells: induction of cluster formation, histamine synthesis, and early mast cell differentiation antigens. J Immunol (2008) 1.15
SWAP-70 regulates c-kit-induced mast cell activation, cell-cell adhesion, and migration. Mol Cell Biol (2004) 1.10
Comparative immunophenotypic analysis of human mast cells, blood basophils and monocytes. Immunology (1996) 1.09
Mast cell function: a new vision of an old cell. J Histochem Cytochem (2014) 1.08
Hematopoietic cytokines for cardiac repair: mobilization of bone marrow cells and beyond. Basic Res Cardiol (2011) 0.91
Novel protective effects of stem cell factor in a murine model of acute septic peritonitis. Dependence on MCP-1. Am J Pathol (2000) 0.87
TNF-alpha and IL-6 induce differentiation in the human basophilic leukaemia cell line KU812. Immunology (1994) 0.87
Stem cell factor-dependent human cord blood derived mast cells express alpha- and beta-tryptase, heparin and chondroitin sulphate. Immunology (1996) 0.86
The PI3-kinase/mTOR-targeting drug NVP-BEZ235 inhibits growth and IgE-dependent activation of human mast cells and basophils. PLoS One (2012) 0.85
Kit signaling is involved in melanocyte stem cell fate decisions in zebrafish embryos. Development (2013) 0.83
Effects of nerve growth factor (NGF) and other fibroblast-derived growth factors on immature human mast cells (HMC-1). Immunology (1998) 0.83
Mastocytosis: a paradigmatic example of a rare disease with complex biology and pathology. Am J Cancer Res (2013) 0.80
Nerve growth factor-beta induces mast-cell marker expression during in vitro culture of human umbilical cord blood cells. Immunology (2000) 0.80
Role of mast cells, stem cell factor and protease-activated receptor-2 in tubulointerstitial lesions in IgA nephropathy. Inflamm Res (2010) 0.78
Long-term treatment with imatinib results in profound mast cell deficiency in Ph+ chronic myeloid leukemia. Oncotarget (2015) 0.76
Immunoprofiling of human uterine mast cells identifies three phenotypes and expression of ERβ and glucocorticoid receptor. F1000Res (2017) 0.75
Interleukin-9 (IL-9) and NPM-ALK each generate mast cell hyperplasia as single 'hit' and cooperate in producing a mastocytosis-like disease in mice. Oncotarget (2010) 0.75
Phenotypic characterization of skin lesions in urticaria pigmentosa and mastocytomas. Arch Dermatol Res (1995) 0.75
Current approach to cutaneous mastocytosis in childhood. Turk Pediatri Ars (2016) 0.75
Dexamethasone inhibits the development of mast cells from dispersed human fetal liver cells cultured in the presence of recombinant human stem cell factor. Immunology (1995) 0.75
Orthopaedic case of the month: Recurrent thigh pain in a 44-year-old man. Clin Orthop Relat Res (2012) 0.75
Mastocytosis in Children. Curr Allergy Asthma Rep (2017) 0.75
Diagnostic criteria and classification of mastocytosis: a consensus proposal. Leuk Res (2001) 4.87
A survey of 215 non-hemophilic patients with inhibitors to Factor VIII. Thromb Haemost (1981) 4.39
Recombinant human granulocyte colony-stimulating factor: effects on normal and leukemic myeloid cells. Science (1986) 3.92
Standards and standardization in mastocytosis: consensus statements on diagnostics, treatment recommendations and response criteria. Eur J Clin Invest (2007) 3.58
Gene organization and structure of two transcriptional units from Methanococcus coding for ribosomal proteins and elongation factors. Can J Microbiol (1989) 3.38
High plasma levels of factor VIII and the risk of recurrent venous thromboembolism. N Engl J Med (2000) 2.86
The kit ligand, stem cell factor. Adv Immunol (1994) 2.86
Genetic-physical mapping of a photosynthetic gene cluster from R. capsulata. Cell (1984) 2.68
MDR1 gene expression and treatment outcome in acute myeloid leukemia. J Natl Cancer Inst (1991) 2.50
Laparoscopic splenectomy: the clinical practice guidelines of the European Association for Endoscopic Surgery (EAES). Surg Endosc (2008) 2.29
Induction of mast cell proliferation, maturation, and heparin synthesis by the rat c-kit ligand, stem cell factor. Proc Natl Acad Sci U S A (1991) 2.17
Allergen-specific immunotherapy with a monophosphoryl lipid A-adjuvanted vaccine: reduced seasonally boosted immunoglobulin E production and inhibition of basophil histamine release by therapy-induced blocking antibodies. Clin Exp Allergy (2003) 2.08
Probability of recurrence of thrombosis in patients with and without factor V Leiden. Thromb Haemost (1996) 2.07
Templated nucleotide addition and immunoglobulin JH-gene utilization in t(11;14) junctions: implications for the mechanism of translocation and the origin of mantle cell lymphoma. Cancer Res (2001) 1.98
Embryonic expression of a haematopoietic growth factor encoded by the Sl locus and the ligand for c-kit. Nature (1990) 1.94
The rat c-kit ligand, stem cell factor, induces the development of connective tissue-type and mucosal mast cells in vivo. Analysis by anatomical distribution, histochemistry, and protease phenotype. J Exp Med (1991) 1.89
Antithrombin III deficiency and thromboembolism. Clin Haematol (1981) 1.76
Evidence of HLA-DR antigen biosynthesis by human keratinocytes in disease. J Exp Med (1984) 1.75
Effect of IL-3 and stem cell factor on the appearance of human basophils and mast cells from CD34+ pluripotent progenitor cells. J Immunol (1992) 1.70
Functional transplant of megabase human immunoglobulin loci recapitulates human antibody response in mice. Nat Genet (1997) 1.67
Recombinant human stem cell factor synergises with GM-CSF, G-CSF, IL-3 and epo to stimulate human progenitor cells of the myeloid and erythroid lineages. Exp Hematol (1991) 1.65
Activation of the human c-kit product by ligand-induced dimerization mediates circular actin reorganization and chemotaxis. EMBO J (1991) 1.63
Identification of profilin as a novel pollen allergen; IgE autoreactivity in sensitized individuals. Science (1991) 1.62
Standardization of flow cytometry in myelodysplastic syndromes: a report from an international consortium and the European LeukemiaNet Working Group. Leukemia (2012) 1.57
The role of recombinant stem cell factor in early B cell development. Synergistic interaction with IL-7. J Immunol (1991) 1.56
Neutrophil granulocyte-committed cells can be driven to acquire dendritic cell characteristics. J Exp Med (1998) 1.54
Support of human hematopoiesis in long-term bone marrow cultures by murine stromal cells selectively expressing the membrane-bound and secreted forms of the human homolog of the steel gene product, stem cell factor. Proc Natl Acad Sci U S A (1992) 1.52
In vivo stimulation of granulopoiesis by recombinant human granulocyte colony-stimulating factor. Proc Natl Acad Sci U S A (1987) 1.50
Lack of DNA synthesis among CD34+ cells in cord blood and in cytokine-mobilized blood. Br J Haematol (1996) 1.48
Solid tumors and factor VIII antibodies. Thromb Haemost (1999) 1.48
Isolation of c-kit receptor-expressing cells from bone marrow, peripheral blood, and fetal liver: functional properties and composite antigenic profile. Blood (1991) 1.45
Effects of erythropoietin on platelet reactivity and thrombopoiesis in humans. Blood (2000) 1.45
Inhalation scintigraphy with iodine-123-labeled interferon gamma-1b: pulmonary deposition and dose escalation study in healthy volunteers. J Nucl Med (1997) 1.44
What have mast cells to do with edema formation, the consecutive repair and fibrinolysis? Int Arch Allergy Immunol (1998) 1.44
Calcium pyrophosphate dihydrate crystal deposition disease of the temporomandibular joint. Oral Surg Oral Med Oral Pathol Oral Radiol Endod (1998) 1.44
A comparative study on demographic, hematological, and cytogenetic findings and prognosis in acute myeloid leukemia with and without leukemia cutis. Ann Hematol (2002) 1.44
Low risk for hepatitis C in hemophiliacs given a high-purity, pasteurized factor VIII concentrate. International Study Group. Ann Intern Med (1990) 1.44
Systemic mastocytosis with associated clonal haematological non-mast cell lineage diseases: a histopathological challenge. J Clin Pathol (2004) 1.43
Further evidence for lymphokine overproduction in severe aplastic anemia. Blood (1988) 1.43
The c-kit receptor ligand functions as a mast cell chemoattractant. Blood (1992) 1.42
Generation of human dendritic cells/Langerhans cells from circulating CD34+ hematopoietic progenitor cells. Blood (1996) 1.42
ERCP and balloon dilation is a valuable alternative to surgical biliodigestive anastomosis in the long common channel syndrome in childhood. Endoscopy (1995) 1.40
Transient lupus anticoagulants in children: stepwise disappearance of diagnostic features. Thromb Haemost (2000) 1.39
Autoimmune reactions in patients with silicone breast implants. Wien Klin Wochenschr (1996) 1.39
A comparison of the Bethesda and New Oxford methods of factor VIII antibody assay. Thromb Haemost (1982) 1.39
Thrombocytopenia associated with low-molecular-weight heparin. Lancet (1991) 1.39
Effects of dental amalgam and its components of histamine release from human basophils and tissue mast cells. Wien Klin Wochenschr (1998) 1.39
[Retro- and prospective studies on the value of clinical and laboratory chemical data in acute appendicitis]. Chirurg (1990) 1.38
Novel CBF beta-MYH11 fusion transcripts and alternative splicing in acute myeloid leukemia with inversion of chromosome 16. Blood (1995) 1.38
Regulation of mouse peritoneal mast cell secretory function by stem cell factor, IL-3 or IL-4. J Immunol (1993) 1.38
Profilins constitute a novel family of functional plant pan-allergens. J Exp Med (1992) 1.35
Report of the Working Party on Acquired Inhibitors of Coagulation: studies of the "lupus" anticoagulant. Thromb Haemost (1983) 1.34
Lupus anticoagulants and thrombosis. A study of 25 cases and review of the literature. Haemostasis (1985) 1.34
Interleukin-3 is a differentiation factor for human basophils. Blood (1989) 1.34
Mast cell typing: demonstration of a distinct hematopoietic cell type and evidence for immunophenotypic relationship to mononuclear phagocytes. Blood (1989) 1.33
Glycosylated hemoglobins (GHb): an index of red cell survival. Blood (1982) 1.32
Development of human mast cells from umbilical cord blood cells by recombinant human and murine c-kit ligand. Proc Natl Acad Sci U S A (1993) 1.30
Diagnostic value of immunostaining for tryptase in patients with mastocytosis. Am J Surg Pathol (1998) 1.28
Ligation of E-cadherin on in vitro-generated immature Langerhans-type dendritic cells inhibits their maturation. Blood (2000) 1.28
Impact of HLA class I high-resolution mismatches on chronic graft-versus-host disease and survival of patients given hematopoietic stem cell grafts from unrelated donors. Bone Marrow Transplant (2005) 1.28
Recombinant human stem cell factor stimulates differentiation of mast cells from dispersed human fetal liver cells. Blood (1992) 1.28
Acquired inhibitors in nonhemophilic patients. Haemostasis (1974) 1.26
Interleukin 3 activates human blood basophils via high-affinity binding sites. Proc Natl Acad Sci U S A (1989) 1.26
Recombinant human granulocyte colony stimulating factor: molecular and biological characterization. Immunobiology (1986) 1.26
Peripheral nerve lesions in haemophilia. J Neurol (1981) 1.25
Endocarditis and aortal embolization caused by Aspergillus terreus in a patient with acute lymphoblastic leukemia in remission: diagnosis by peripheral-blood culture. J Clin Microbiol (1998) 1.24
Prognostic impact of age and gender in 897 untreated patients with primary myelodysplastic syndromes. Ann Oncol (2009) 1.22
Secondary prevention of myocardial infarction: a comparison of acetylsalicylic acid, placebo and phenprocoumon. Haemostasis (1980) 1.22
Conversion of the major birch pollen allergen, Bet v 1, into two nonanaphylactic T cell epitope-containing fragments: candidates for a novel form of specific immunotherapy. J Clin Invest (1997) 1.22
Soluble stem cell factor in human serum. Blood (1993) 1.21
Nonanaphylactic synthetic peptides derived from B cell epitopes of the major grass pollen allergen, Phl p 1, for allergy vaccination. FASEB J (2001) 1.21
The addition of plerixafor is safe and allows adequate PBSC collection in multiple myeloma and lymphoma patients poor mobilizers after chemotherapy and G-CSF. Bone Marrow Transplant (2010) 1.19
Induction of antibody responses to new B cell epitopes indicates vaccination character of allergen immunotherapy. Eur J Immunol (1999) 1.17
Clinical and biologic diversity of leukemias occurring in patients with mastocytosis. Leuk Lymphoma (2000) 1.16
Cell surface structures on human basophils and mast cells: biochemical and functional characterization. Adv Immunol (1992) 1.15
Long-term outcome and quality of life of patients who are alive and in complete remission more than two years after allogeneic and syngeneic stem cell transplantation. Bone Marrow Transplant (2002) 1.14
Interleukin 4 promotes expression of mast cell ICAM-1 antigen. Proc Natl Acad Sci U S A (1991) 1.13
Mutation analysis of C-KIT in patients with myelodysplastic syndromes without mastocytosis and cases of systemic mastocytosis. Br J Haematol (2001) 1.13
TGF-beta 1 promotes in vitro generation of dendritic cells by protecting progenitor cells from apoptosis. J Immunol (1997) 1.13
Protein C deficiency in two Austrian families. Thromb Haemost (1983) 1.12
Soluble CD23 reliably reflects disease activity in B-cell chronic lymphocytic leukemia. J Clin Oncol (1994) 1.12
The human cardiac mast cell: localization, isolation, phenotype, and functional characterization. Blood (1994) 1.12
Expression of the target receptor CD33 in CD34+/CD38-/CD123+ AML stem cells. Eur J Clin Invest (2007) 1.11
Nonhematopoietic tumor cell lines express stem cell factor and display c-kit receptors. Blood (1992) 1.11